Abstract: A pharmaceutical composition for treating retinitis pigmentosa that includes statin-loaded nanoparticles. The pharmaceutical composition is used in a method of treating retinitis pigmentosa involving administering to a subject in need thereof the pharmaceutical composition that includes statin-loaded nanoparticles.

Abstract: The present invention can provide an epoxy resin composition that can have flexibility, toughness, adhesiveness, and high disassemblability by heating, and can provide a cured product and a laminate thereof. An epoxy resin composition according to the present invention contains an epoxy resin (A) with an epoxy equivalent in the range of 500 to 10,000 g/eq, an epoxy resin (B) with an epoxy equivalent in the range of 100 to 300 g/eq, and a compound (C) with an anthracene dimer skeleton. The epoxy resin (A) is represented by the following general formula (1), and the compound (C) has two or more groups containing an epoxy group or two or more groups containing a curable group.

Abstract: Provided is a method for producing sulfurized olefin, the method including reacting an olefin compound (a) represented by R1R2C?CHR3 . . . (1) (in Formula (1), R1 and R2 each are alkyl groups, respectively, R3 is a hydrogen atom or an alkyl group, and the total number of carbon atoms of R1, R2 and R3 is 2 to 20) with sulfur in the presence of hydrogen to give a dialkyl polysulfide (A).

Abstract: The present invention relates to a laminate including a two-dimensional material and an adhesive sheet having a base material and an adhesive layer whose adhesive force decreases due to ultraviolet rays or heat, in which an adhesive force A at 25° C. of the adhesive layer before the ultraviolet rays or heat applies, to a silicon wafer is 1.0 N/20 mm to 20.0 N/20 mm when the adhesive layer is subjected to 180° peeling at a tensile speed of 300 mm/min, and a surface roughness of an adhesive surface of the adhesive layer after the ultraviolet rays or heat has been applied is 0.01 ?m to 8.00 ?m.

Abstract: A probe has a base sequence that does not hybridize with a nucleic acid of a mammal under stringent conditions, and has a sequence including a base sequence set forth in any of SEQ ID NOs:1 to 673. A probe set includes two or more kinds of the probes, and the two or more kinds of the probes do not hybridize with each other under stringent conditions.

Abstract: A medicament and method for treating circulatory diseases accompanied by inflammation of a cardiovascular system related to IL-6 and/or IL-1? and a medicament and method for treating circulatory diseases accompanied by inflammation of a cardiovascular system related to IL-6 and/or IL-1?. The method involves administering a medicament including an IL-6 and/or IL-1? suppressor including a compound represented by the following formula (I) where R1 and R2 are each independently a hydrogen atom or a methyl group, or a pharmaceutically acceptable salt thereof.

Abstract: This power conversion device includes a control unit that controls a switching operation of a switching element of the inverter unit. The control unit is configured to switch between frequency modulation control and phase shift control, based on the output from the output converter unit, and execute. Then, the control unit is configured to, when switching between frequency modulation control and phase shift control, execute overlap control for executing the phase shift control while executing the frequency modulation control, in a predetermined switching operation range.

Abstract: A heat-transfer member (1) is used in a cooling system in which an alcohol serves as a coolant. The heat-transfer member (1) has: a heat-receiving surface (11) configured such that it can receive heat from a heat-generating body; and a heat-dissipating surface (12) configured such that it can dissipate, to the coolant, the heat received at the heat-receiving surface (11). The heat-dissipating surface (12) has a plurality of pores (121) whose average pore diameter is 5 nm or more and 1,000 nm or less. A cooling system can be configured by causing the coolant to contact the heat-dissipating surface (12) of the heat-transfer member (1).

Abstract: A method in which carbon dioxide can be efficiently fixed, calcium carbonate that is a valuable can be efficiently produced from carbon dioxide, and a waste gypsum board can be effectively recycled without being wasted as it is by using the waste gypsum board for fixing carbon dioxide. This method includes: bringing a first solution containing an alkali metal hydroxide and gas containing carbon dioxide into contact with each other to produce a second solution containing an alkali metal salt; and bringing the second solution and a gypsum-containing material into contact with each other to produce calcium carbonate.

Abstract: An immunoregulatory agent containing a regulatory agent that regulates Dedicator of cytokinesis 2 (DOCK2)-mediated Rac activation as an active ingredient is provided.

Abstract: The present disclosure provides a high-pressure hydrogen apparatus gas seal member which is excellent in durability and is capable of sufficiently suppressing an occurrence of a blister fracture. A high-pressure hydrogen apparatus gas seal member of the present disclosure is a high-pressure hydrogen apparatus gas seal member made of a crosslinked product of an elastomer composition which comprises an elastomer and fibrous carbon nanostructures having an average length of 100 ?m or more and 1000 ?m or less, wherein the fibrous carbon nanostructures have a surface fractal dimension of 2.3 or more and 3.0 or less or a radius of gyration of 50 nm or more and 500 nm or less, and further the fibrous carbon nanostructures has an inner diameter of 4.0 nm or less.

Abstract: The present invention provides a method for culturing a fish germ stem cell, including culturing the stem cell on a surface coated with vitronectin and in a medium containing the following 8 components: (1) insulin, (2) selenium, (3) transferrin, (4) L-ascorbic acid, (5) FGF2, (6) TGF?, (7) NaHCO3 or KHCO3, (8) L-glutamine.

Abstract: The present invention provides a cell adhesion sheet in which the adhesion of platelets is suppressed and the adhesion of cells is excellent. The cell adhesion sheet according to the embodiment of the present invention is formed of a composition containing a compound represented by Formula (1).

Abstract: A compound represented by formula (I), its racemic form, or their salt, wherein X represents an oxygen atom, a nitrogen atom or a sulfur atom; R1 represents an unsaturated aliphatic hydrocarbon group; R2 represents a saturated or unsaturated aliphatic hydrocarbon group; and R3 represents choline, ethanolamine, inositol or serine.

Abstract: Provided is a medical device containing a polyurethane resin elastomer that can achieve both biocompatibility and physical properties. The medical device in an embodiment contains a polyurethane resin elastomer and water contained in the polyurethane resin elastomer. The polyurethane resin elastomer contains polyethylene glycol and a polyisocyanate as constituents, the polyethylene glycol has a number average molecular weight of 200 or more and 2200 or less, and the polyethylene glycol is present in an amount of 1 mass % or higher and lower than 50 mass % based on 100 mass % of the constituents of the polyurethane resin elastomer.

Abstract: A DPP-IV inhibitor and a food with functional claims, which comprises methylated catechin as a novel active ingredient, are provided.

Abstract: Methods are disclosed herein for promoting survival of a donor liver in a recipient subject, wherein the donor liver is homozygous for rs738409:G mutation in the patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene. The method can include administering to the subject glutathione (GSH) and/or a nucleic acid molecule encoding a component of the ferroptosis pathway (such as GPX4).

Abstract: Provided is a pharmaceutical composition effective for anti-cancer immunostimulating therapies.

Abstract: According to the present invention, there is provided a superconducting induction rotating machine 1 that has a stator for which a plurality of superconducting armature coils are placed along the circumferential direction, and a rotor provided rotatably around a central axis line in a state opposing the stator with a predetermined gap interposed, wherein the rotor is configured of a complex consisting of a cylindrical electrically conductive material layer disposed on a side opposing the stator, and a magnetic material layer disposed on an opposite side to the side opposing the stator of the electrically conductive material layer, and wherein the superconducting induction rotating machine 1 rotationally drives the rotor by generating a rotational torque in the rotor with a rotating magnetic field created by the armature coils while the superconducting armature coils disposed on the stator being cooled to a superconducting state.

Abstract: An organic electroluminescence device exhibiting high light emission efficiency is provided, which includes a first electrode, a second electrode, and an emission layer disposed between the first electrode and the second electrode. The emission layer may include a compound represented by Formula 1.